Molecular Screening for Hepatitis Virus

HBV can cause acute and chronic infection.There is currently no role for molecular testing in the diagnosis of acute hepatitis B other than in the detection of asymptomatic patients during pretransfusion screening of blood products. To facilitate an understanding of the utility of molecular testing for chronic hepatitis B, the four stages of chronic hepatitis B infection that are currently recognized, as well as an additional entity, occult hepatitis B, that can be diagnosed only by sensitive nucleic acid amplification methods, are reviewed in detail, including available therapeutic age

 

  • Serological and molecular testing
  • Laboratory methods for Diagnosis & management
  • Current molecular methods

Related Conference of Molecular Screening for Hepatitis Virus

October 29-30, 2018

4th World Congress on Digestive & Metabolic Diseases

| San Francisco, California, USA
November 07-08, 2018

World Summit on Liver Cirrhosis and Hepatitis

Singapore
December 17-18, 2018

3rd World Liver Congress

Abu Dhabi, UAE
January 30-31, 2019

16th World Congress on Gastroenterology & Therapeutics

Bangkok, Thailand
March 04-05, 2019

20th World Congress on Gastroenterology

Berlin, Germany
June 17-18, 2019

World Liver Conference 2019

Columbus, Ohio, U.S.A
July 08-09, 2019

14th Euro-Global Gastroenterology Conference

Zurich, Switzerland
July 15-16, 2019

7th International Conference on Hepatology

Sydney, Australia
October 14-15, 2019

19th World Gastroenterologists Summit

Sydney, Australia

Molecular Screening for Hepatitis Virus Conference Speakers

Recommended Sessions

Related Journals

Are you interested in